Irf2bp2 is down regulated by lipopolysaccharides (LPS) and ablation of Irf2bp2 in macrophages activates inflammation, impairs macrophage cholesterol efflux and worsens atherosclerosis (7). The gene discussed is IRF2BP2; the disease is atherosclerosis.